News

The JAK inhibitor demonstrated promising efficacy and safety.

Click here to answer this week's poll.

While receiving checkpoint inhibitor therapy, patients with advanced melanoma benefitted from a telehealth exercise program.

The autosomal recessive disorder is primarily caused by mutations in the TGM5 gene and less frequently in the CSTA gene.

In this week’s Pointers with Portela, the 208SkinDoc gives his best product recommendations for Mother's Day gifts.

If you weren’t able to attend SCALE 2023 or want to review the latest data, our full recap has you covered.

Cream containing epigallocatechin gallate (EGCG) or EGCG combined with L-carnitine yielded a greater anti-sebum effect.

New research into the disease’s pathogenesis may inform future treatment options.

In part 3 of this Frontline Forum series, John M. Strasswimmer, MD, PhD; Andrew H. Weinstein, MD; Neal Bhatia, MD; Laura Ferris, MD; and Aaron S. Farberg, MD, discuss solutions for managing and treating patients with basal cell carcinoma.

The first-of-a-kind product uses a topically applied small peptide fluorescent dye and handheld imager to non-invasively detect a biomarker of early tissue changes.

The adalimumab biosimilar will be commercially available in the US starting July 1, 2023.

Topline results for the topical sodium channel blocker are expected in 2024.

As many as 1 in 5 patients with psoriasis experience depression as a comorbidity.

Renata Block, MMS, PA-C, spearheaded a skin cancer screening event for veterans in her hometown.

Researchers analyzed dermatoses associated with obesity and insulin resistance in pediatric patients.

A recent study supports a degree of correlation between trough serum concentration of infliximab and clinical response to infliximab in patients with the condition.

In this month’s Cosmetic Conundrums column, Zoe Diana Draelos, MD, discusses solutions for ethnic and Afro-textured hair care.

Catch up on coverage from the final day of SCALE 2023.

Let us know what you learned from the 2023 SCALE meeting in Nashville, Tennessee.

The over-the-counter serum helped improve skin recovery after laser treatment, according to a poster presentation at SCALE 2023.

Goldberg reviewed non-invasive skin tightening procedures and laser complications at SCALE 2023.

Catch up on coverage from the fourth day of SCALE 2023.

Aerosolized dry shampoo is the latest personal care product to contain detectable levels of benzene, according to Bunick’s SCALE 2023 session.

A poster presentation from SCALE 2023 examined if 2 creams containing Macrocystis pyrifera ferment exhibited anti-aging, anti-inflammatory, and healing properties.

Benjamin encouraged attendees at SCALE 2023 to think beyond just topicals for pediatric acne.

Ablon presented sessions on nutrition, exosome therapy, and treating the hair-challenged patient at SCALE 2023.

Catch up on coverage from the third day of SCALE 2023.

Anthony Rossi, MD, reviewed how beauty standards have changed over centuries and what providers need to consider when performing procedures at SCALE 2023.

Cheryl Burgess, MD, FAAD, reviewed the symptoms and diagnoses of collected case studies of dermal filler AEs at SCALE 2023.